N
NeoPharm Co Ltd
KOSDAQ:092730
NeoPharm Co Ltd
KOSDAQ:092730
Price:
17 170
KRW
-0.64%
Market Closed
Market Cap:
₩275.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
KR |
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
Alamos Gold Inc
TSX:AGI
|
CA |
|
Logitech International SA
NASDAQ:LOGI
|
CH |
|
Acutus Medical Inc
OTC:AFIB
|
US |
|
Electrolux AB
OTC:ELRXF
|
SE |
|
Silver Elephant Mining Corp
TSX:ELEF
|
CA |
|
I
|
Innoprise Plantations Bhd
KLSE:INNO
|
MY |
|
GE Vernova Inc
MIL:1GEV
|
US |
|
K
|
Knowmerce Corp
KOSDAQ:473980
|
KR |
|
V
|
Versatile Creative Bhd
KLSE:VERSATL
|
MY |
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
AU |
|
C
|
Centuria Industrial Reit
ASX:CIP
|
AU |
|
P
|
Progressive Path Group Holdings Ltd
HKEX:1581
|
HK |
|
S
|
Starcore International Mines Ltd
OTC:SHVLF
|
CA |
|
SRJ Technologies Group PLC
ASX:SRJ
|
JE |
|
Columbus A/S
CSE:COLUM
|
DK |
|
R
|
R Stahl AG
XHAM:RSL2
|
DE |
|
Australian Silica Quartz Group Ltd
ASX:ASQ
|
AU |
|
Marsden Maritime Holdings Ltd
NZX:MMH
|
NZ |
|
Gke Corporation Ltd
SGX:595
|
SG |
|
Wereldhave NV
AEX:WHA
|
NL |
Balance Sheet
Balance Sheet Decomposition
NeoPharm Co Ltd
NeoPharm Co Ltd
Balance Sheet Decomposition is not available for
NeoPharm Co Ltd
NeoPharm Co Ltd
Balance Sheet
NeoPharm Co Ltd
NeoPharm Co Ltd
Currency: KRW
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
591
|
1 921
|
1 656
|
1 119
|
2 658
|
1 682
|
1 799
|
6 662
|
8 004
|
7 613
|
4 244
|
8 421
|
5 515
|
11 188
|
7 049
|
10 883
|
11 881
|
18 234
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
860
|
325
|
520
|
731
|
772
|
989
|
1 584
|
1 419
|
1 986
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
591
|
1 921
|
1 656
|
1 119
|
2 658
|
822
|
1 474
|
6 142
|
7 273
|
6 841
|
3 255
|
6 837
|
4 096
|
9 202
|
7 049
|
10 883
|
11 881
|
18 234
|
|
| Short-Term Investments |
6 500
|
4 003
|
3 833
|
5 475
|
5 589
|
7 600
|
8 665
|
7 647
|
5 118
|
16 616
|
27 184
|
34 000
|
80 000
|
84 992
|
98 000
|
102 602
|
100 109
|
108 290
|
|
| Total Receivables |
3 292
|
2 479
|
3 191
|
3 778
|
3 950
|
3 960
|
4 440
|
3 591
|
4 700
|
4 611
|
7 426
|
9 184
|
9 626
|
8 863
|
8 045
|
7 665
|
10 383
|
12 762
|
|
| Accounts Receivables |
3 160
|
2 426
|
2 914
|
3 036
|
3 504
|
3 496
|
3 990
|
3 561
|
4 660
|
4 463
|
7 339
|
9 099
|
9 473
|
8 739
|
7 967
|
7 596
|
10 323
|
12 662
|
|
| Other Receivables |
132
|
53
|
277
|
742
|
446
|
464
|
450
|
30
|
40
|
148
|
87
|
85
|
153
|
124
|
78
|
69
|
59
|
100
|
|
| Inventory |
566
|
767
|
1 138
|
1 151
|
1 507
|
2 125
|
2 605
|
2 847
|
4 245
|
4 157
|
4 844
|
6 844
|
5 840
|
8 090
|
7 973
|
8 749
|
10 195
|
12 676
|
|
| Other Current Assets |
289
|
555
|
820
|
861
|
390
|
609
|
431
|
893
|
984
|
711
|
350
|
488
|
699
|
418
|
416
|
1 371
|
1 935
|
1 088
|
|
| Total Current Assets |
11 237
|
9 724
|
10 638
|
12 383
|
14 094
|
15 976
|
17 940
|
21 640
|
23 052
|
33 707
|
44 047
|
58 937
|
101 680
|
113 551
|
121 484
|
131 270
|
134 502
|
153 050
|
|
| PP&E Net |
6 786
|
8 642
|
10 014
|
10 190
|
10 145
|
9 530
|
8 957
|
8 416
|
8 259
|
8 635
|
8 918
|
10 441
|
10 496
|
10 121
|
9 743
|
9 341
|
29 244
|
29 764
|
|
| PP&E Gross |
6 786
|
8 642
|
10 014
|
10 190
|
10 145
|
9 530
|
8 957
|
8 416
|
8 259
|
8 635
|
8 918
|
10 441
|
10 496
|
10 121
|
9 743
|
9 341
|
29 244
|
29 764
|
|
| Accumulated Depreciation |
584
|
923
|
1 573
|
2 389
|
3 232
|
3 968
|
4 440
|
5 017
|
5 655
|
5 935
|
6 134
|
6 326
|
6 985
|
7 500
|
7 940
|
8 129
|
8 689
|
10 120
|
|
| Intangible Assets |
1 215
|
1 135
|
1 744
|
1 351
|
1 272
|
1 167
|
1 358
|
1 255
|
1 098
|
1 229
|
1 203
|
1 171
|
2 384
|
2 380
|
2 055
|
1 786
|
2 237
|
1 951
|
|
| Goodwill |
0
|
0
|
5 903
|
5 298
|
4 629
|
3 934
|
2 785
|
1 519
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
335
|
379
|
186
|
811
|
367
|
19
|
0
|
0
|
56
|
78
|
69
|
80
|
89
|
115
|
117
|
118
|
136
|
135
|
|
| Long-Term Investments |
1 254
|
2 667
|
2 807
|
1 644
|
1 797
|
1 789
|
1 945
|
2 357
|
6 962
|
2 716
|
1 863
|
1 656
|
7 035
|
5 992
|
9 192
|
12 059
|
10 320
|
6 891
|
|
| Other Long-Term Assets |
793
|
1 088
|
1 032
|
1 361
|
1 697
|
1 728
|
1 774
|
649
|
983
|
143
|
595
|
643
|
1 058
|
818
|
818
|
773
|
1 020
|
649
|
|
| Other Assets |
0
|
0
|
5 903
|
5 298
|
4 629
|
3 934
|
2 785
|
1 519
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
21 621
N/A
|
23 636
+9%
|
32 326
+37%
|
33 038
+2%
|
34 001
+3%
|
34 142
+0%
|
34 759
+2%
|
35 836
+3%
|
40 409
+13%
|
46 509
+15%
|
56 695
+22%
|
72 928
+29%
|
122 742
+68%
|
132 978
+8%
|
143 408
+8%
|
155 347
+8%
|
177 459
+14%
|
192 440
+8%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
410
|
292
|
683
|
455
|
638
|
700
|
789
|
1 030
|
2 065
|
2 263
|
2 760
|
3 462
|
3 174
|
4 194
|
4 347
|
3 703
|
6 435
|
5 030
|
|
| Accrued Liabilities |
514
|
191
|
279
|
204
|
154
|
241
|
320
|
347
|
248
|
377
|
636
|
759
|
862
|
737
|
766
|
885
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
700
|
700
|
0
|
116
|
0
|
0
|
0
|
0
|
0
|
0
|
400
|
4 000
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
257
|
384
|
145
|
536
|
260
|
432
|
24
|
400
|
40
|
57
|
64
|
0
|
256
|
290
|
457
|
412
|
635
|
500
|
|
| Other Current Liabilities |
1 075
|
1 285
|
1 123
|
1 088
|
2 064
|
1 821
|
1 616
|
1 972
|
5 027
|
5 059
|
5 555
|
8 673
|
8 139
|
5 655
|
7 371
|
8 136
|
9 875
|
9 597
|
|
| Total Current Liabilities |
2 256
|
2 152
|
2 930
|
2 983
|
3 116
|
3 309
|
2 749
|
3 749
|
7 380
|
7 756
|
9 015
|
12 894
|
12 831
|
14 877
|
12 941
|
13 137
|
16 945
|
15 128
|
|
| Long-Term Debt |
484
|
377
|
569
|
161
|
354
|
0
|
900
|
0
|
0
|
0
|
0
|
400
|
4 000
|
19
|
102
|
0
|
430
|
129
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
237
|
504
|
416
|
440
|
659
|
909
|
774
|
942
|
406
|
182
|
98
|
347
|
218
|
364
|
61
|
0
|
58
|
299
|
|
| Total Liabilities |
2 978
N/A
|
3 033
+2%
|
3 915
+29%
|
3 585
-8%
|
4 129
+15%
|
4 218
+2%
|
4 423
+5%
|
4 691
+6%
|
7 786
+66%
|
7 938
+2%
|
9 113
+15%
|
13 641
+50%
|
17 049
+25%
|
15 260
-10%
|
13 103
-14%
|
13 137
+0%
|
17 433
+33%
|
15 555
-11%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
2 578
|
3 326
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
4 104
|
4 104
|
4 104
|
4 104
|
4 104
|
8 014
|
|
| Retained Earnings |
8 378
|
11 409
|
12 653
|
13 335
|
13 806
|
13 813
|
15 315
|
17 125
|
18 558
|
24 450
|
33 279
|
44 757
|
59 085
|
71 100
|
83 848
|
96 106
|
113 603
|
130 569
|
|
| Additional Paid In Capital |
8 752
|
8 068
|
13 536
|
13 566
|
13 536
|
13 543
|
13 536
|
13 536
|
13 536
|
13 536
|
13 536
|
13 536
|
45 133
|
45 133
|
45 684
|
45 684
|
45 684
|
41 737
|
|
| Unrealized Security Profit/Loss |
0
|
56
|
49
|
4
|
17
|
20
|
0
|
0
|
0
|
18
|
30
|
81
|
73
|
66
|
33
|
485
|
179
|
0
|
|
| Treasury Stock |
1 065
|
2 144
|
1 343
|
669
|
669
|
669
|
0
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
|
| Other Equity |
0
|
0
|
215
|
514
|
514
|
514
|
2 245
|
566
|
521
|
484
|
314
|
138
|
23
|
6
|
619
|
519
|
507
|
757
|
|
| Total Equity |
18 643
N/A
|
20 603
+11%
|
28 411
+38%
|
29 453
+4%
|
29 872
+1%
|
29 924
+0%
|
30 336
+1%
|
31 146
+3%
|
32 624
+5%
|
38 571
+18%
|
47 582
+23%
|
59 287
+25%
|
105 693
+78%
|
117 718
+11%
|
130 305
+11%
|
142 211
+9%
|
160 026
+13%
|
176 885
+11%
|
|
| Total Liabilities & Equity |
21 621
N/A
|
23 636
+9%
|
32 326
+37%
|
33 038
+2%
|
34 001
+3%
|
34 142
+0%
|
34 759
+2%
|
35 836
+3%
|
40 409
+13%
|
46 509
+15%
|
56 695
+22%
|
72 928
+29%
|
122 742
+68%
|
132 978
+8%
|
143 408
+8%
|
155 347
+8%
|
177 459
+14%
|
192 440
+8%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
7
|
6
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
8
|
8
|
16
|
16
|
16
|
16
|
|
Switch to:
Switch to:
See Also
Discover More
